Assessing cost-effectiveness of alternative bus technologies: Evidence from US transit agencies

被引:10
|
作者
Avenali, Alessandro [1 ]
Catalano, Giuseppe [1 ]
Giagnorio, Mirko [1 ,2 ]
Matteucci, Giorgio [1 ]
机构
[1] Sapienza Univ Rome, Dept Comp Control & Management Engn, Rome, Italy
[2] Sapienza Univ Rome, Dept Mech & Aerosp Engn, Rome, Italy
关键词
Transit buses; Electric buses; Life Cycle Cost; Total Cost of Ownership; Environmental benefit; LIFE-CYCLE ASSESSMENT; ASSESSING STANDARD COSTS; HEAVY-DUTY TRUCKS; NATURAL-GAS; ELECTRIC BUS; FUEL; VEHICLES; DIESEL; EMISSIONS; TRANSPORT;
D O I
10.1016/j.trd.2023.103648
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
This paper aims to analyze overall economic and environmental performances of alternative bus powertrains by focusing on U.S. active fleets in different urban contexts. We define a life cycle cost model related to bus technologies by referring to real-world data of 256 transport operators, which provide more than 80% of total vehicle revenue miles produced by urban transit mode across the U.S. in 2019. The proposed method includes some service parameters that significantly affect the supply cost (e.g., service speed, annual mileage), on which we perform scenario and sensitivity analysis. Results show that electric buses are cost-competitive in large cities and metropolises, where urban bus routes are characterized by a high level of congestion, high service frequency, and the highest marginal impact of harmful emissions. In towns and suburban areas, where bus routes are longer and faster, full electric technology still faces both economic and technical barriers.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS - MODEL FOR ASSESSING TRAINING INVESTMENT
    CULLEN, JG
    SAWZIN, SA
    SISSON, GR
    SWANSON, RA
    TRAINING AND DEVELOPMENT JOURNAL, 1978, 32 (01): : 24 - &
  • [42] Assessing the Costs and Cost-Effectiveness of Genomic Sequencing
    Christensen, Kurt D.
    Dukhovny, Dmitry
    Siebert, Uwe
    Green, Robert C.
    JOURNAL OF PERSONALIZED MEDICINE, 2015, 5 (04) : 470 - 486
  • [43] ASSESSING EXPOSURE CONTROL STRATEGY COST-EFFECTIVENESS
    BIRKNER, LR
    SALZMAN, LS
    AMERICAN INDUSTRIAL HYGIENE ASSOCIATION JOURNAL, 1986, 47 (01): : 50 - 54
  • [44] The cost-effectiveness of biopharmaceuticals A look at the evidence
    Wilson, Andrew W.
    Neumann, Peter J.
    MABS, 2012, 4 (02) : 281 - 288
  • [45] Measuring the cost effectiveness of multimode bus transit in the presence of accident risks
    Yu, Ming-Miin
    Fan, Chih-Ku
    TRANSPORTATION PLANNING AND TECHNOLOGY, 2006, 29 (05) : 383 - 407
  • [46] COST-EFFECTIVENESS OF TESAMORELIN IN THE TREATMENT OF LIPOHYPERTROPHY IN THE US
    Azimpour, K.
    Tremblay, G.
    de Chantal, M.
    Marsolais, C.
    VALUE IN HEALTH, 2020, 23 : S175 - S175
  • [47] The Role of Cost-Effectiveness in US Vaccination Policy
    Kim, Jane J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (19): : 1760 - 1761
  • [48] Assessing Cost-effectiveness From the LOGICA Trial-Is Laparoscopic Gastrectomy Worth the Cost?
    McIntyre, Caitlin A.
    Drebin, Harrison M.
    Strong, Vivian E.
    JAMA SURGERY, 2023, 158 (02) : 129 - 129
  • [49] COST-EFFECTIVENESS OF UNIVERSAL INFLUENZA VACCINATION IN THE US
    Clements, K. M.
    Chancellor, J.
    DeLong, K.
    Nichol, K. L.
    Thompson, D.
    VALUE IN HEALTH, 2010, 13 (03) : A189 - A189
  • [50] Assessing effectiveness and cost-effectiveness of concurrency reduction for HIV prevention
    Enns, E. A.
    Brandeau, M. L.
    Igeme, T. K.
    Bendavid, E.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2011, 22 (10) : 558 - 567